The predictive effect of the systemic immune-inflammation index for patients with small-cell lung cancer

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J. Clin. 69(1), 7–34 (2019).
  MedlineGoogle Scholar
• 2. Sabatino SA, Thompson TD, Smith JL et al. Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J. Cancer Survivorship 7(1), 32–43 (2013).
  MedlineGoogle Scholar
• 3. Ettinger DS, Akerley W, Borghaei H et al. Non-small cell lung cancer, version 2.2013. J. Natl Compr. Cancer Netw. 11(6), 645–653 (2013).
  Google Scholar
• 4. Xie D, Marks R, Zhang M et al. Nomograms predict overall survival for patients with small-cell lung cancer incorporating pretreatment peripheral blood markers. J. Thorac. Oncol. 10(8), 1213–1220 (2015). •• Small-cell lung cancer is characterized by aggressive biology, rapid growth and early metastasis. The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio incorporating hematological markers could more accurately predict individualized survival probability of small-cell lung cancer.
  MedlineGoogle Scholar
• 5. De Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6(1), 24–37 (2006).
  MedlineGoogle Scholar
• 6. Placke T, Salih HR, Kopp HG. GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity. J. Immunol. 189(1), 154–160 (2012).
  Medline CASGoogle Scholar
• 7. Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial–mesenchymal-like transition and promotes metastasis. Cancer Cell 20(5), 576–590 (2011).
  Medline CASGoogle Scholar
• 8. Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell 24(1), 130–137 (2013).
  Medline CASGoogle Scholar
• 9. Gil-Bernabe AM, Ferjancic S, Tlalka M et al. Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood 119(13), 3164–3175 (2012).
  Medline CASGoogle Scholar
• 10. Halazun KJ, Hardy MA, Rana AA et al. Negative impact of neutrophil–lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann. Surg. 250(1), 141–151 (2009).
  MedlineGoogle Scholar
• 11. Dan J, Zhang Y, Peng Z et al. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PLoS ONE 8(3), e58184 (2013).
  Medline CASGoogle Scholar
• 12. Hamilton G, Rath B, Klameth L, Hochmair MJ. Small cell lung cancer: recruitment of macrophages by circulating tumor cells. Oncoimmunology 5(3), e1093277 (2016).
  MedlineGoogle Scholar
• 13. Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediat. Inflamm. 2016, 6058147 (2016).
  MedlineGoogle Scholar
• 14. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 454(7203), 436–444 (2008).
  Medline CASGoogle Scholar
• 15. Hu B, Yang XR, Xu Y et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin. Cancer Res. 20(23), 6212–6222 (2014).
  Medline CASGoogle Scholar
• 16. Fankhauser CD, Sander S, Roth L et al. Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. Br. J. Cancer 118(6), 825–830 (2018).
  Medline CASGoogle Scholar
• 17. Chen JH, Zhai ET, Yuan YJ et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J. Gastroenterol. 23(34), 6261–6272 (2017).
  MedlineGoogle Scholar
• 18. Wang K, Diao F, Ye Z et al. Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Chin. J. Cancer 36(1), 75 (2017).
  MedlineGoogle Scholar
• 19. Geng Y, Shao Y, Zhu D et al. Systemic immune-inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysis. Sci. Rep. 6, 39482 (2016).
  Medline CASGoogle Scholar
• 20. Fan L, Wang R, Chi C et al. Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients. Prostate 78(4), 250–256 (2018).
  Medline CASGoogle Scholar
• 21. Kang KH, Efird JT, Sharma N et al. Prognostic potential of neutrophil-to-lymphocyte ratio and lymphocyte nadir in stage III non-small-cell lung cancer. Future Oncol. 13(16), 1405–1414 (2017).
  CASGoogle Scholar
• 22. Guo D, Zhang J, Jing W et al. Prognostic value of systemic immune-inflammation index in patients with advanced non-small-cell lung cancer. Future Oncol. 14(25), 2643–2650 (2018). • Studies show that inflammatory processes can contribute to non-small-cell lung cancer progression and is associated with poor prognosis.
  CASGoogle Scholar
• 23. Wang X, Teng F, Kong L, Yu J. Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer. OncoTargets Ther. 9, 5761–5770 (2016).
  MedlineGoogle Scholar
• 24. Hu K, Lou L, Ye J, Zhang S. Prognostic role of the neutrophil–lymphocyte ratio in renal cell carcinoma: a meta-analysis. BMJ Open 5(4), e006404 (2015).
  MedlineGoogle Scholar
• 25. Laguna MP. Re: change in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy. J. Urol. 196(6), 1634–1635 (2016).
  MedlineGoogle Scholar
• 26. Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic immune-inflammation index, based on platelet counts and neutrophil–lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J. Exp. Med. 236(4), 297–304 (2015).
  Medline CASGoogle Scholar
• 27. Wang L, Wang C, Wang J, Huang X, Cheng Y. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 143(10), 2077–2086 (2017).
  MedlineGoogle Scholar
• 28. Jiang W, Chen Y, Huang J et al. Systemic immune-inflammation index predicts the clinical outcome in patients with nasopharyngeal carcinoma: a propensity score-matched analysis. Oncotarget 8(39), 66075–66086 (2017).
  MedlineGoogle Scholar
• 29. Xie QK, Chen P, Hu WM et al. The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor. J. Translational Med. 16(1), 273 (2018).
  Medline CASGoogle Scholar
• 30. Tang Jn, Goyal H, Yu S, Luo H. Prognostic value of systemic immune-inflammation index (SII) in cancers: a systematic review and meta-analysis. J. Lab. Precis. Med. 3, 29 (2018). •• Systemic immune-inflammation index has been shown to be predictive in many malignancies.
  Google Scholar
• 31. Tecchio C, Scapini P, Pizzolo G, Cassatella MA. On the cytokines produced by human neutrophils in tumors. Semin. Cancer Biol. 23(3), 159–170 (2013).
  Medline CASGoogle Scholar
• 32. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J. Intern. Med. 248(3), 171–183 (2000).
  Medline CASGoogle Scholar
• 33. Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett. 267(2), 204–215 (2008).
  Medline CASGoogle Scholar
• 34. Muller I, Munder M, Kropf P, Hansch GM. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol. 30(11), 522–530 (2009).
  MedlineGoogle Scholar
• 35. Rachidi S, Metelli A, Riesenberg B et al. Platelets subvert T cell immunity against cancer via GARP-TGFβ axis. Sci. Immunol. 2(11), eaai7911 (2017).
  MedlineGoogle Scholar
• 36. Kusumanto YH, Dam WA, Hospers GaP, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6(4), 283–287 (2003). • Liberation of VEGF from these compartments could well be of importance for tumor angiogenesis. Platelets and neutrophils could be important compartments for circulating VEGF.
  Medline CASGoogle Scholar
• 37. Cristina F, Glenn D. Dual roles for immunity in gastrointestinal cancers. J. Clin. Oncol. 28(26), 4045–4051 (2010).
  MedlineGoogle Scholar
• 38. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646–674 (2011). • Inflammation runs through the development of tumor, and the role of inflammation in tumor has been paid more and more attention.
  Medline CASGoogle Scholar
• 39. Templeton AJ, Mcnamara MG, Seruga B et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl Cancer Inst. 106(6), dju124 (2014).
  MedlineGoogle Scholar
• 40. Aziz MH, Sideras K, Aziz NA et al. The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort study. Ann. Surg. 270(1), 139–146 (2019).
  MedlineGoogle Scholar